Skip to main content

Dodge & Cox

Position in NBIX — Neurocrine Biosciences Inc

CIK 200217 San Francisco, CA

Position in NBIX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$719,437,014
-$61,768,582 QoQ
Shares Held
5,461,037
-0.9% QoQ
Ownership
5.43%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 95.20285249852729.ToString("F0")% Shared 0.ToString("F0")% None 4.797147501472706.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Dodge & Cox holds $3,836,131,353 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (18.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
5,461,037 $719,437,014

All Filings in NBIX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $719,437,014 5,461,037
2025-12-31 $781,205,596 5,508,042
2025-09-30 $780,038,034 5,556,618
2025-06-30 $699,692,851 5,566,814
2025-03-31 $612,129,414 5,534,624
2024-12-31 $411,742,012 3,016,425
2024-09-30 $148,382,620 1,287,820
2024-06-30 $176,330,489 1,280,820
2024-03-31 $174,502,452 1,265,244
2023-12-31 $165,983,869 1,259,744
2023-09-30 $24,030,225 213,602